Dr. O'Malley on Racial and Economic Barriers to Screening in CRC

Video

In Partnership With:

Denalee O'Malley, PhD, discusses racial and economic barriers to colorectal screening in colorectal cancer.

Denalee O'Malley, PhD, assistant professor, Department of Family Medicine and Community Health, Research Division, Rutgers Robert Wood Johnson Medical School, discusses racial and economic barriers to colorectal screening in colorectal cancer (CRC).

The disparities that affect screening for CRC stem from structural racism embedded in the health-care delivery system, O'Malley says. These disparities are interconnected, and they include racism, income inequality, geographic disparities, and the organization and delivery of health care, O'Malley explains.

Moreover, there are many different types of CRC screening tests, all with different levels of efficacy and intervals of testing, O’Malley adds. A FIT test is an annual screening, compared with a colonoscopy, which involves a 10-year interval if tests come back normal, O’Malley continues.

Community health centers play a key part in screenings, as they are considered a primary care safety net, O’Malley explains. However, over 20% of community health center patient populations are uninsured, adding another disparity to screening, O’Malley concludes.

Related Videos
Mike Lattanzi, MD, medical oncologist, Texas Oncology
Vikram M. Narayan, MD, assistant professor, Department of Urology, Emory University School of Medicine, Winship Cancer Institute; director, Urologic Oncology, Grady Memorial Hospital
Stephen V. Liu, MD
S. Vincent Rajkumar, MD
Pashtoon Murtaza Kasi, MD, MS
Naseema Gangat, MBBS
Samilia Obeng-Gyasi, MD, MPH,
Kian-Huat Lim, MD, PhD
Saurabh Dahiya, MD, FACP, associate professor, medicine (blood and marrow transplantation and cellular therapy), Stanford University School of Medicine, clinical director, Cancer Cell Therapy, Stanford BMT and Cell Therapy Division
Muhamed Baljevic, MD